Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Orthofix highlights positive business trends in fourth quarter

Orthofix highlights positive business trends in fourth quarter

13th January 2012

Orthofix has highlighted a five percent year-on-year growth in sales during the fourth quarter of 2011.

The medical device manufacturer's preliminary unaudited quarterly fiscal results show a record net sales total of $151.3 million (98.78 million pounds), with its full-year total now expected to reach $578.7 million.

Robert Vaters, the company's president and chief executive officer, said these results – which represent the second consecutive quarter of record sales – show Orthofix is still growing faster than the rest of the market.

The announcement coincides with the agreement of a new deal with MTF, focusing on the development and commercialisation of new technology for bone grafting applications, to be launched in 2013.

"We are adding to our biologic pipeline and are very well positioned to help MTF fulfil its mission and meet the market's increased demand for novel bone grafting solutions," Mr Vaters added.

Over the last year, Orthofix has added several products to its range, including its bone graft substitute Collage in November 2011.ADNFCR-8000103-ID-801264161-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.